September 24, 2016 11:29 PM ET


Company Overview of Ocera Therapeutics, Inc.

Key Executives for Ocera Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Linda S. Grais M.D.25 RelationshipsChief Executive Officer, President, Secretary and Director60
Eckard Weber M.D.44 RelationshipsCo-Founder, Chairman and Member of Audit Committee66
Michael Byrnes M.B.A.No RelationshipsChief Financial Officer and Treasurer39
Gaurav Aggarwal M.D.9 RelationshipsChief Business Officer43
Stan Bukofzer M.D.18 RelationshipsChief Medical Officer60

Ocera Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Eckard Weber M.D. 44 RelationshipsOcera Therapeutics, Inc.66
Linda S. Grais M.D. 25 RelationshipsOcera Therapeutics, Inc.60
Anne M. VanLent 57 RelationshipsOcera Therapeutics, Inc.68
Steven P. James 21 RelationshipsAntiva Biosciences, Inc.58
Michael F. Powell Ph.D. 92 RelationshipsSofinnova Ventures, Inc.61
View All Board Members

Ocera Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Anne M. VanLent57 Relationships3 Executives
Compensation Committee Steven P. James21 Relationships2 Executives
Nominating Committee Anne M. VanLent57 Relationships3 Executives
Corporate Governance Committee Anne M. VanLent57 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation$180.4K
Total Value of Options$459.6K
Compensation as of Fiscal Year 2015
Ocera Therapeutics, Inc. CEO Compensation
Industry Average


Endo International plc Announces Executive Changes
September 23, 2016 11:00 AM ET
Gujarat Themis Biosyn Ltd. Announces Board Changes
September 23, 2016 10:41 AM ET
Merck KGaA Appoints Isabel De Paoli as Chief Strategy Officer, Effective 1 October 2016
September 23, 2016 12:00 AM ET
Valeritas Holdings, Inc. Announces Board Changes, Effective October 10, 2016
September 22, 2016 12:00 PM ET
Lannett Company, Inc. Announces Resignation of Mahendra Dedhiya as Chief of Scientific Affairs
September 22, 2016 10:53 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ocera Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at